Related Articles
Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression
Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells
Oxaliplatin and infliximab synergize to induce regression of colon cancer
Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo
P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions